鹏华国证疫苗与生物科技ETF发起式联接C(021293)申购赎回 |
|
|
| 报告期 |
期初总份额(份) |
期末总份额(份) |
期间总申购份额(份) |
期间总赎回份额(份) |
期间净申赎份额(份) |
净申赎比例 |
| 2025/12/31 |
89,940 |
3,769,140 |
15,807,400 |
12,128,200 |
3,679,200 |
4090.71% |
| 2025/12/31 |
761,533 |
3,769,140 |
8,488,030 |
5,480,420 |
3,007,610 |
394.94% |
| 2025/9/30 |
735,620 |
761,533 |
5,520,260 |
5,494,350 |
25,910 |
3.52% |
| 2025/6/30 |
89,940 |
735,620 |
1,799,070 |
1,153,390 |
645,680 |
717.9% |
| 2025/6/30 |
83,314 |
735,620 |
1,419,870 |
767,568 |
652,302 |
782.95% |
| 2025/3/31 |
89,940 |
83,314 |
379,199 |
385,825 |
-6,626 |
-7.37% |
| 2024/12/31 |
9,762 |
89,940 |
173,792 |
93,614 |
80,178 |
821.31% |
| 2024/12/31 |
9,762 |
89,940 |
173,792 |
93,614 |
80,178 |
821.31% |
*注:新浪财经提醒:以上数据由合作伙伴提供,仅供参考,交易请以正式公告数据为准。